Pennsylvania – Dozens of medicinal products for children and infants are being voluntarily recalled by a Pennsylvania manufacturer, the U.S. Food & Drug Administration announced late last month. Parent company McNeil Consumer Healthcare listed 46 different medicine brands it was recalling, all liquid medicines designed for infants or for children age 2 to 11. That included 24 Tylenol items, including concentrated infant drops, and various cold and flue medicines. McNeil also recalled 15 different types of Motrin, 6 brands of Zyrtec, and 1 brand of Benadryl, all of which are products for either children or infants. See a complete list of recalled products, with product code numbers, at McNeilProductRecall.com. McNeil announced April 30th that it is voluntarily recalling all lots that have not yet expired of certain over-the-counter children’s and infants’ liquid products manufactured in the United States and distributed in the U.S., Canada, and 10 other countries. McNeil said it “is initiating this voluntary recall because some of these products may not meet required quality standards.” The company said the “recall is not being undertaken on the basis of adverse medical events,” but it warns that “as a precautionary measure, parents and caregivers should not administer these products to their children.” Some of the products in the recall may contain a higher concentration of active ingredients than is specified, the company said, while “others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles.” McNeil said that “while the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.” The company is “conducting a comprehensive quality assessment” of its manufacturing operations, before new manufacturing resumes at the plant where recalled products were made. FDA Commissioner, Dr. Margaret A. Hamburg said the FDA wants “to be certain that consumers discontinue using these products” and “know what to do if they have concerns about a specific product.” Hamburg said: “While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality” FDA is “investigating the products and facilities associated with this recall and will provide updates” as it learns more. Contact McNeil at 1-888-222-6036, or mcneilproductrecall.com, and report adverse reactions to the FDA. Story by Jim Reece This email address is being protected from spambots. You need JavaScript enabled to view it.
Monday, 10 May 2010 06:13
Medicine Maker Recalls Infant, Children Tylenol, Motrin Brands
Pennsylvania – Dozens of medicinal products for children and infants are being voluntarily recalled by a Pennsylvania manufacturer, the U.S. Food & Drug Administration announced late last month. Parent company McNeil Consumer Healthcare listed 46 different medicine brands it was recalling, all liquid medicines designed for infants or for children age 2 to 11. That included 24 Tylenol items, including concentrated infant drops, and various cold and flue medicines. McNeil also recalled 15 different types of Motrin, 6 brands of Zyrtec, and 1 brand of Benadryl, all of which are products for either children or infants. See a complete list of recalled products, with product code numbers, at McNeilProductRecall.com. McNeil announced April 30th that it is voluntarily recalling all lots that have not yet expired of certain over-the-counter children’s and infants’ liquid products manufactured in the United States and distributed in the U.S., Canada, and 10 other countries. McNeil said it “is initiating this voluntary recall because some of these products may not meet required quality standards.” The company said the “recall is not being undertaken on the basis of adverse medical events,” but it warns that “as a precautionary measure, parents and caregivers should not administer these products to their children.” Some of the products in the recall may contain a higher concentration of active ingredients than is specified, the company said, while “others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles.” McNeil said that “while the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.” The company is “conducting a comprehensive quality assessment” of its manufacturing operations, before new manufacturing resumes at the plant where recalled products were made. FDA Commissioner, Dr. Margaret A. Hamburg said the FDA wants “to be certain that consumers discontinue using these products” and “know what to do if they have concerns about a specific product.” Hamburg said: “While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality” FDA is “investigating the products and facilities associated with this recall and will provide updates” as it learns more. Contact McNeil at 1-888-222-6036, or mcneilproductrecall.com, and report adverse reactions to the FDA. Story by Jim Reece This email address is being protected from spambots. You need JavaScript enabled to view it.Latest from
- Richard Forster previews this week's Amador County Board of Supervisors meeting with host, Tom Slivick. (2 of 2)
- Richard Forster on TSPN TV News December 7, 2015 (1 of 2)
- Ebbetts Pass (State Route 4) Closed for Winter
- State HWY 89 Closed for the Winter
- Richard Forster on TSPN TV News November 23, 2015 (2 of 2)
